BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang L, Gao AX, He YL, Xu MJ, Lu HJ. Immunotherapy in SMARCB1 (INI-1)-deficient sinonasal carcinoma: Two case reports. World J Clin Cases 2023; 11(32): 7911-7919 [PMID: 38073679 DOI: 10.12998/wjcc.v11.i32.7911]
URL: https://www.wjgnet.com/2307-8960/full/v11/i32/7911.htm
Number Citing Articles
1
Shuhan Zhao, Hao Du, Zhanjie Zhang, Jinsong Yang, You Zhou, Guixiang Xiao, Hui Ma, Caini Lan, Jinzi Liang, Kunyu Yang, Lu Wen. SMARCB1/INI-1-Deficient sinonasal carcinoma demonstrates a poor prognosis but favorable clinical outcomes after PD-1/PD-L1 inhibitor therapy: A case seriesScience Progress 2025; 108(1) doi: 10.1177/00368504251315075
2
Elisabetta Xue, Dara Bracken-Clarke, Harris Krause, Tolulope Adeyelu, Mark G. Evans, Dilara Akbulut, Martha Quezado, Nishant Gandhi, Alex Farrell, Heloisa P. Soares, Emil Lou, Minh Phan, Rusha Patel, Ari M. Vanderwalde, Andrew Elliott, Conor E. Steuer, Nabil F. Saba, Daniel J. Lubin, Nyall R. London, James L. Gulley, Charalampos S. Floudas. Characterization of Somatostatin Receptor 2 Gene Expression and Immune Landscape in Sinonasal MalignanciesCancers 2024; 16(23): 3931 doi: 10.3390/cancers16233931
3
Neha Mittal, Saurabh Nagar, Asawari Patil, Swapnil Ulhas Rane, Palgun Nisarga, Katha Rabade, Amit Janu, Deepa Nair, Shiva Thiagarajan, Sarbani Ghosh Laskar, Kumar Prabhash, Munita Bal. SMARCB1-deficient Sinonasal CarcinomaAmerican Journal of Surgical Pathology 2025;  doi: 10.1097/PAS.0000000000002364